To include your compound in the COVID-19 Resource Center, submit it here.

Incivo regulatory update

EMA's CHMP issued a positive opinion recommending approval of an MAA for Incivo telaprevir from Johnson & Johnson

Read the full 182 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE